Analysts’ Viewpoint
Demand for pneumatic nebulizers is increasing across the globe due to the rise in prevalence of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Environmental pollution, smoking, and changing lifestyles are contributing to the growth in prevalence of respiratory disorders. Technological advancements in healthcare devices and increase in number of geriatric patients are driving the global pneumatic nebulizers market.
Development of technologically advanced pneumatic nebulizers presents significant opportunities for market players. Companies are focusing on accelerating product development in order to gain competitive edge over other players. However, drug loss during delivery is likely to hamper pneumatic nebulizers market revenue during the forecast period.
Pneumatic nebulizers are devices that convert liquid medication into a fine mist or aerosol that can be inhaled through a mouthpiece or mask. These devices use compressed air or oxygen to create mist, making them more portable and easy to use than other types of nebulizer.
Pneumatic nebulizers are used to treat respiratory conditions such as asthma, COPD, and cystic fibrosis. Portable nebulizer machine is also used in industrial and laboratory settings for nebulization of liquids and solutions.
These devices use compressed air or oxygen to create a high-velocity stream of air that breaks up the liquid medication into small droplets, which can be inhaled. Jet nebulizers are used in healthcare settings; however, they can also be used at home under the guidance of a healthcare provider.
Vented and breath-actuated are the two primary types of pneumatic nebulizer. Pneumatic nebulizer is the most widely used device due to its suitability for all types of medications. Furthermore, the device is easy to handle and less expensive than other types of nebulizers (ultrasonic and mesh).
Request a sample to get extensive insights into the Pneumatic Nebulizers Market
Asthma, cystic fibrosis, and COPD are chronic lung conditions that affect millions of people globally. Prevalence of these conditions varies by country and region; however, they are considered major public health concerns.
Asthma is a chronic lung disease that causes inflammation and narrowing of the airways, making it difficult to breathe. According to the World Health Organization (WHO), asthma affected around 262 million people across the world in 2019. It is the most common chronic pediatric disease that affects 14% of all children across the globe every year.
Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, causing buildup of thick, sticky mucus. It affects around 35,000 people in the U.S. every year.
COPD is a group of lung conditions that makes breathing difficult. The most common causes of COPD are smoking and long-term exposure to air pollution. According to the World Health Organization (WHO), COPD accounted for 3.23 million deaths worldwide in 2019. Nearly 90% COPD deaths occur in low & middle income countries.
Advancements in technology have made nebulizers more portable and convenient for patients to use at home. Modern nebulizers are smaller, lighter, and battery-operated, which makes them easy to carry around and use in various settings. Hence, patients are likely to use these devices as directed by the healthcare provider.
Some nebulizers carry features such as wireless connectivity, which allows patients to track their treatment progress and receive reminders to take medication. This is likely to improve compliance, and thereby lead to better health outcomes.
Request a custom report on Pneumatic Nebulizers Market
In terms of product type, the global pneumatic nebulizers market has been bifurcated into breath-actuated nebulizer and vented nebulizer. The breath-actuated segment dominated the global market with significant share in 2021.
Breath-actuated pneumatic nebulizers have a higher drug delivery capacity and less dosage waste. Hence, they provide advanced inhalation therapy. These factors are ascribed to the segment's dominance of the market.
Based on application, the COPD segment accounted for major share of the global market in 2021. COPD is more prevalent than asthma, cystic fibrosis, and others. It is a progressive disease, which makes breathing more difficult as it worsens.
Severe COPD could lead to respiratory failure, which can be fatal. Hence, demand for pneumatic nebulizers is increasing among COPD patients.
In terms of end-user, the global pneumatic nebulizers market has been divided into hospitals & clinics, home healthcare, and others. The home healthcare segment accounted for the largest share of the global market in 2021. Pneumatic nebulizers enable individuals to administer medication to themselves, which could help reduce the number of hospital visits and spread of viruses.
North America accounted for major share of the global market in 2021. The market in the region is likely to expand at a high CAGR from 2022 to 2031. This can be ascribed to the high rate of adoption of pneumatic nebulizers in the region.
Rise in prevalence of various respiratory disorders such as COPD, asthma, and cystic fibrosis is propelling market expansion in the region. Technological advancements in healthcare and increase in adoption of home healthcare are the other factors fueling market statistics in the region.
As per pneumatic nebulizers market report, Asia Pacific held the second largest share in 2021. The market in the region is likely to grow at a rapid pace from 2022 to 2031. This can be ascribed to the increase in number of COPD and asthma patients in Asia Pacific.
According to Global Burden of Disease Study 2019, about 72 million people in India suffered from obstructive airway diseases (OAD) such as asthma and COPD during the year. Additionally, technological advancements and new product development are expected to augment market progress in the region during the forecast period.
The global pneumatic nebulizers market is fragmented, with the presence of large number of local as well as international players. Expansion of product portfolio and mergers & acquisitions are key strategies adopted by the leading players.
Prominent players in the industry are Beurer GmbH, Besco Medical Co., Ltd., Bremed Ltd., Drive DeVilbiss Healthcare, GE HealthCare, Koninklijke Philips N.V., Morepen Laboratories Ltd., Nidek Medical Products, Inc., OMRON Healthcare, Inc., PARI Pharma GmbH, Rossmax International Ltd., SunMed, and Vectura Group plc.
Each of these players has been profiled in the pneumatic nebulizers market report based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.
|
Attribute |
Detail |
|
Size in 2021 |
US$ 648.0 Mn |
|
Forecast (Value) in 2031 |
More than US$ 1.3 Bn |
|
Growth Rate (CAGR) |
7.3% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Mn/Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global industry was valued at US$ 648.0 Mn in 2021.
It is projected to reach more than US$ 1.3 Bn by 2031.
The CAGR is anticipated to be 7.3% from 2022 to 2031.
Surge in prevalence of COPD, asthma, and cystic fibrosis; and advancement in technology.
North America is expected to account for the largest share during the forecast period.
Beurer GmbH, Besco Medical Co., Ltd., Bremed Ltd., Drive DeVilbiss Healthcare, GE HealthCare, Koninklijke Philips N.V., Morepen Laboratories Ltd., Nidek Medical Products, Inc., OMRON Healthcare, Inc., PARI Pharma GmbH, Rossmax International Ltd., SunMed, and Vectura Group plc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pneumatic Nebulizers Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pneumatic Nebulizers Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Industry Events
5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Pneumatic Nebulizers Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Breath-actuated Nebulizer
6.3.2. Vented Nebulizer
6.4. Market Attractiveness Analysis, by Product Type
7. Global Pneumatic Nebulizers Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Chronic Obstructive Pulmonary Disease (COPD)
7.3.2. Asthma
7.3.3. Cystic Fibrosis
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Pneumatic Nebulizers Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals & Clinics
8.3.2. Home Healthcare
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Pneumatic Nebulizers Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Pneumatic Nebulizers Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Breath-actuated Nebulizer
10.2.2. Vented Nebulizer
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Chronic Obstructive Pulmonary Disease (COPD)
10.3.2. Asthma
10.3.3. Cystic Fibrosis
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals & Clinics
10.4.2. Home Healthcare
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Pneumatic Nebulizers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Breath-actuated Nebulizer
11.2.2. Vented Nebulizer
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Chronic Obstructive Pulmonary Disease (COPD)
11.3.2. Asthma
11.3.3. Cystic Fibrosis
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals & Clinics
11.4.2. Home Healthcare
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Pneumatic Nebulizers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Breath-actuated Nebulizer
12.2.2. Vented Nebulizer
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Chronic Obstructive Pulmonary Disease (COPD)
12.3.2. Asthma
12.3.3. Cystic Fibrosis
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals & Clinics
12.4.2. Home Healthcare
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Pneumatic Nebulizers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Breath-actuated Nebulizer
13.2.2. Vented Nebulizer
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Chronic Obstructive Pulmonary Disease (COPD)
13.3.2. Asthma
13.3.3. Cystic Fibrosis
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals & Clinics
13.4.2. Home Healthcare
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Pneumatic Nebulizers Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Breath-actuated Nebulizer
14.2.2. Vented Nebulizer
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Chronic Obstructive Pulmonary Disease (COPD)
14.3.2. Asthma
14.3.3. Cystic Fibrosis
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals & Clinics
14.4.2. Home Healthcare
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Beurer GmbH
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Besco Medical Co., Ltd.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Bremed Ltd.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. Drive DeVilbiss Healthcare
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. GE HealthCare
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Koninklijke Philips N.V.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Morepen Laboratories Ltd.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Nidek Medical Products, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. OMRON Healthcare, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. PARI Pharma GmbH
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
15.3.11. Rossmax International Ltd.
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Strategic Overview
15.3.12. SunMed
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Strategic Overview
15.3.13. Vectura Group plc
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Strategic Overview
List of Tables
Table 01: Global Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 06: North America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 07: North America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 08: North America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 09: Europe Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 10: Europe Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 11: Europe Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: Europe Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 13: Asia Pacific Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 14: Asia Pacific Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Asia Pacific Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Latin America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 18: Latin America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 19: Latin America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 20: Latin America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Middle East & Africa Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 22: Middle East & Africa Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Middle East & Africa Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 24: Middle East & Africa Pneumatic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Pneumatic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Pneumatic Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 03: Global Pneumatic Nebulizers Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 04: Global Pneumatic Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031
Figure 05: Global Pneumatic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031
Figure 06: Global Pneumatic Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 07: Global Pneumatic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 08: Global Pneumatic Nebulizers Market Analysis and Forecast, by Region, 2021 and 2031
Figure 09: Global Pneumatic Nebulizers Market Attractiveness Analysis, by Region, 2022–2031
Figure 10: North America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031
Figure 11: North America Pneumatic Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 12: North America Pneumatic Nebulizers Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 13: North America Pneumatic Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031
Figure 14: North America Pneumatic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031
Figure 15: North America Pneumatic Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 16: North America Pneumatic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 17: North America Pneumatic Nebulizers Market Analysis and Forecast, by Country, 2021 and 2031
Figure 18: North America Pneumatic Nebulizers Market Attractiveness Analysis, by Country, 2022–2031
Figure 19: Europe Pneumatic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031
Figure 20: Europe Pneumatic Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 21: Europe Pneumatic Nebulizers Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 22: Europe Pneumatic Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031
Figure 23: Europe Pneumatic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031
Figure 24: Europe Pneumatic Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 25: Europe Pneumatic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 26: Europe Pneumatic Nebulizers Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 27: Europe Pneumatic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 28: Asia Pacific Pneumatic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031
Figure 29: Asia Pacific Pneumatic Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 30: Asia Pacific Pneumatic Nebulizers Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 31: Asia Pacific Pneumatic Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031
Figure 32: Asia Pacific Pneumatic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031
Figure 33: Asia Pacific Pneumatic Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 34: Asia Pacific Pneumatic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 35: Asia Pacific Pneumatic Nebulizers Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 36: Asia Pacific Pneumatic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 37: Latin America Pneumatic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031
Figure 38: Latin America Pneumatic Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 39: Latin America Pneumatic Nebulizers Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 40: Latin America Pneumatic Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031
Figure 41: Latin America Pneumatic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031
Figure 42: Latin America Pneumatic Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 43: Latin America Pneumatic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 44: Latin America Pneumatic Nebulizers Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 45: Latin America Pneumatic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 46: Middle East & Africa Pneumatic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031
Figure 47: Middle East & Africa Pneumatic Nebulizers Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 48: Middle East & Africa Pneumatic Nebulizers Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 49: Middle East & Africa Pneumatic Nebulizers Market Analysis and Forecast, by Application, 2021 and 2031
Figure 50: Middle East & Africa Pneumatic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031
Figure 51: Middle East & Africa Pneumatic Nebulizers Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 52: Middle East & Africa Pneumatic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 53: Middle East & Africa Pneumatic Nebulizers Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 54: Middle East & Africa Pneumatic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 55: Global Pneumatic Nebulizers Market Share Analysis/Ranking, by Company, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Pneumatic Nebulizers Market
